EMS, officially known as EMS S/A, is a leading Brazilian pharmaceutical company headquartered in Jaguariúna, São Paulo. Founded in 1964, EMS has established itself as a key player in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of generic and branded medications. With a strong presence across Brazil and significant operations in Latin America, EMS has achieved notable milestones, including becoming one of the largest pharmaceutical companies in Brazil. The company is renowned for its extensive portfolio of high-quality products, which includes prescription medications, over-the-counter drugs, and a variety of therapeutic classes. EMS distinguishes itself through its commitment to innovation and quality, ensuring that its offerings meet the highest industry standards. With a robust market position, EMS continues to contribute significantly to the healthcare sector, making it a trusted name among healthcare professionals and patients alike.
How does EMS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
EMS's score of 32 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, EMS, headquartered in Brazil, reported total carbon emissions of approximately 22,000,490 kg CO2e. This figure includes 18,242,150 kg CO2e from Scope 1 emissions, 3,668,750 kg CO2e from Scope 2 emissions, and 3,771,590 kg CO2e from Scope 3 emissions. The data reflects a comprehensive approach to emissions reporting, as all three scopes have been disclosed. Despite the significant emissions figures, EMS has not established specific reduction targets or climate pledges as of the latest data. The emissions data is cascaded from its parent company, EMS S.A., indicating a corporate family relationship that influences its climate commitments and reporting practices. As a current subsidiary, EMS is part of a broader commitment to sustainability, although specific initiatives or targets have not been detailed in the available information. The company continues to monitor its emissions and may align future strategies with industry standards and best practices in climate action.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | |
|---|---|
| Scope 1 | 18,242,150 |
| Scope 2 | 3,668,750 |
| Scope 3 | 3,771,590 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
EMS has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
